Guy van Meter
Corporate Officer/Principal presso Adimab LLC
Profilo
Guy van Meter is currently the Vice President & Head-Business Development at Adimab LLC since 2012.
Prior to his current position, he held the role of Head-Business Development & Strategic Alliances at Pfizer Inc. and Head-Business Development & Technology Licensing at Dyax Corp.
Mr. van Meter completed his undergraduate degree at Babson College.
Posizioni attive di Guy van Meter
Società | Posizione | Inizio |
---|---|---|
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Corporate Officer/Principal | - |
Precedenti posizioni note di Guy van Meter
Società | Posizione | Fine |
---|---|---|
DYAX CORP. | Corporate Officer/Principal | - |
PFIZER, INC. | Corporate Officer/Principal | - |
Formazione di Guy van Meter
Babson College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PFIZER, INC. | Health Technology |
Aziende private | 2 |
---|---|
Dyax Corp.
Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Health Technology |
- Borsa valori
- Insiders
- Guy van Meter